MARC Record from marc_columbia

LEADER: 04407cam a2200661Ii 4500
001 14308167
005 20190925160619.0
008 190529t20192019dcuab b 000 0 eng d
035 $a(OCoLC)on1102639063
040 $aNRC$beng$erda$cNRC$dNDD$dYDXIT$dOCLCO$dKSU$dOCLCO$dYDX$dOCLCF
019 $a1102640860
020 $a9780309486484$q(paperback)
020 $a0309486483$q(paperback)
029 1 $aAU@$b000065653485
035 $a(OCoLC)1102639063$z(OCoLC)1102640860
043 $an-us---
050 4 $aRC568.O45$bM43 2019
060 4 $aWM 284
082 04 $a615.7/822$223
049 $aZCUA
245 00 $aMedications for opioid use disorder save lives /$cCommittee on Medication-Assisted Treatment for Opioid Use Disorders ; Alan I. Leshner and Michelle Mancher, editors ; Board on Health Sciences Policy ; Health and Medicine Division.
264 1 $aWashington, DC :$bThe National Academies Press,$c[2019]
264 4 $c©2019
300 $axviii, 156 pages :$bcolor illustrations, color maps ;$c23 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
490 1 $aA consensus study report of the Natonal Academies of Sciences, Engineering, Medicine
520 $a"The opioid crisis in the United States has come about because of excessive use of these drugs for both legal and illicit purposes and unprecedented levels of consequent opioid use disorder (OUD). More than 2 million people in the United States are estimated to have OUD, which is caused by prolonged use of prescription opioids, heroin, or other illicit opioids. OUD is a life-threatening condition associated with a 20-fold greater risk of early death due to overdose, infectious diseases, trauma, and suicide. Mortality related to OUD continues to escalate as this public health crisis gathers momentum across the country, with opioid overdoses killing more than 47,000 people in 2017 in the United States. Efforts to date have made no real headway in stemming this crisis, in large part because tools that already exist--like evidence-based medications--are not being deployed to maximum impact"--Publisher's description.
504 $aIncludes bibliographical references.
505 0 $aThe effectiveness of medication-based treatment for opioid use disorder -- Treatment with medications for opioid use disorder in different populations -- Medications for opioid use disorder in various treatment settings -- Barriers to broader use of medications to treat opioid use disorder.
650 0 $aOpioid abuse$xTreatment$zUnited States.
650 0 $aDrug addicts$xRehabilitation$zUnited States.
650 0 $aOpioids$xOverdose$xTreatment$zUnited States.
650 0 $aBrain$xDiseases$xTreatment$zUnited States.
650 0 $aOpioid abuse$xPrevention$xGovernment policy.
650 0 $aMethadone maintenance$zUnited States.
650 0 $aBuprenorphine$xTherapeutic use$zUnited States.
650 0 $aNaloxone$xTherapeutic use$zUnited States.
650 0 $aNaltrexone$xTherapeutic use$zUnited States.
650 2 $aOpiate Substitution Treatment.$0(DNLM)D058850
650 2 $aOpioid-Related Disorders$xtherapy.$0(DNLM)D009293Q000628
650 2 $aDrug Users.$0(DNLM)D055030
650 2 $aDrug Overdose.$0(DNLM)D062787
650 7 $aBrain$xDiseases$xTreatment.$2fast$0(OCoLC)fst00837618
650 7 $aBuprenorphine$xTherapeutic use.$2fast$0(OCoLC)fst00841660
650 7 $aDrug addicts$xRehabilitation.$2fast$0(OCoLC)fst01430276
650 7 $aMethadone maintenance.$2fast$0(OCoLC)fst01018549
650 7 $aOpioid abuse$xTreatment.$2fast$0(OCoLC)fst01430931
651 7 $aUnited States.$2fast$0(OCoLC)fst01204155
700 1 $aLeshner, Alan I.,$d1944-$eeditor.
700 1 $aMancher, Michelle,$eeditor.
710 2 $aNational Academies of Sciences, Engineering, and Medicine (U.S.).$bCommittee on Medication-Assisted Treatment for Opioid Use Disorder.
710 2 $aNational Academies of Sciences, Engineering, and Medicine (U.S.).$bBoard on Health Sciences Policy.
710 2 $aNational Academies of Sciences, Engineering, and Medicine (U.S.).$bHealth and Medicine Division.
776 08 $aOnline version:$tMedications for opioid use disorder save lives.$dWashington, D.C. : National Academies Press, c 2019$z9780309486484$w(OCoLC)1096298025
830 0 $aConsensus study report.
852 00 $boff,sci$hRC568.O45$iM475 2019g